Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN   US09061G1013

Delayed Quote. Delayed Nasdaq - 03/03 04:00:01 pm
108.36 USD   -0.06%
02/25 BIOMARIN PHARMA : reports 4Q loss
02/25 BioMarin Announces Fourth Quarter and Full Year 2014 Financial Re..
02/23DJDrugmaker PTC Therapeutics Exploring Possible Sale -Reuters
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
107.5(c) 108.84(c) 107.07(c) 108.42(c) 108.36(c) Last
1 117 451 1 953 376 921 806 1 139 082 1 015 627 Volume
+1.39% +1.25% -1.63% +1.26% -0.06% Change
More quotes
Company
BioMarin Pharmaceutical, Inc. develops and commercializes innovative pharmaceuticals for serious diseases and medical conditions.The company operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's product portfolio is comprised of... 
Sector
Pharmaceuticals
Calendar
03/03 | 10:00amPresentation
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 877 M
EBIT 2015 -320 M
Net income 2015 -341 M
Debt 2015 172 M
Yield 2015 -
Sales 2016 1 102 M
EBIT 2016 -142 M
Net income 2016 -168 M
Debt 2016 179 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 19,9x
EV / Sales 2016 15,8x
Capitalization 17 244 M
More Financials
Latest news on BIOMARIN PHARMACEUTICAL IN
02/25 BIOMARIN PHARMACEUTICAL : reports 4Q loss
02/25 BIOMARIN PHARMACEUTICAL : Results of Operations and Financial Condition, Financi..
02/25 BioMarin Announces Fourth Quarter and Full Year 2014 Financial Results
02/23DJDrugmaker PTC Therapeutics Exploring Possible Sale -Reuters
02/23 EXCLUSIVE - RARE DISEASE DRUGMAKER P : sources
02/20 BIOMARIN PHARMACEUTICAL : Reports Inducement Grants Under NASDAQ Listing Rule 56..
02/17 JPMORGAN CHASE : JP Morgan Rating Disclosure on BioMarin Pharmaceutical Inc.
02/12 BIOMARIN PHARMACEUTICAL : Prosensa Announces Voluntary Delisting and Advance Liq..
More news
Sector news Generic Pharmaceuticals
01:57aDJToyota Taps First Foreign Vice President
01:47a BRISTOL MYERS SQUIBB : Announces Dividend
01:47a BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Supplemental Bi..
Plus d'actualités du secteur Generic Pharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF